Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MNMD

Mind Medicine MindMed (MNMD)

Mind Medicine MindMed Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNMD
DateTimeSourceHeadlineSymbolCompany
04/05/202422:00Business WireMindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New YorkNASDAQ:MNMDMind Medicine MindMed Inc
02/05/202421:00Business WireMindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
25/04/202421:00Business WireMindMed to Present at Upcoming May Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
02/04/202422:00Business WireMindMed to Present at Upcoming April Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
02/04/202408:00Business WireMindMed Announces Voluntary Delisting from Cboe CanadaNASDAQ:MNMDMind Medicine MindMed Inc
11/03/202423:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
11/03/202422:00Business WireMindMed to Participate in the Leerink Partners 2024 Global Biopharma ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
08/03/202400:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202423:13Business WireMind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private PlacementNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202423:09Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:MNMDMind Medicine MindMed Inc
07/03/202422:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202422:00Business WireMindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
02/03/202405:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
02/03/202401:00Business WireMindMed to Host Conference Call and Webcast to Discuss Data Update for MM120NASDAQ:MNMDMind Medicine MindMed Inc
01/03/202408:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
01/03/202408:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
01/03/202408:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
01/03/202408:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
28/02/202423:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MNMDMind Medicine MindMed Inc
28/02/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
28/02/202423:05Business WireMindMed Reports 2023 Financial Results and Business UpdatesNASDAQ:MNMDMind Medicine MindMed Inc
22/02/202423:00Business WireMindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
07/02/202423:00Business WireMindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
09/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
08/01/202423:45Business WireMindMed Announces Business Update and Anticipated Milestones for 2024NASDAQ:MNMDMind Medicine MindMed Inc
27/12/202308:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
27/12/202308:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
27/12/202308:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
27/12/202308:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
27/12/202308:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
 Showing the most relevant articles for your search:NASDAQ:MNMD